Allspring Global Investments Holdings LLC Acquires 65,833 Shares of Ardent Health Partners, LLC (NYSE:ARDT)

Allspring Global Investments Holdings LLC lifted its position in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) by 9.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 779,601 shares of the company's stock after acquiring an additional 65,833 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.55% of Ardent Health Partners worth $13,136,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in ARDT. R Squared Ltd bought a new position in Ardent Health Partners in the 4th quarter valued at approximately $37,000. Oliver Luxxe Assets LLC bought a new position in shares of Ardent Health Partners during the fourth quarter valued at $1,465,000. JPMorgan Chase & Co. bought a new position in shares of Ardent Health Partners during the third quarter valued at $154,000. Franklin Resources Inc. bought a new position in shares of Ardent Health Partners during the third quarter valued at $15,839,000. Finally, Barclays PLC bought a new position in shares of Ardent Health Partners during the third quarter valued at $385,000.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on ARDT. Leerink Partners raised their price target on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an "outperform" rating in a research note on Tuesday, November 12th. Truist Financial dropped their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Royal Bank of Canada reiterated an "outperform" rating and set a $23.00 price objective on shares of Ardent Health Partners in a research report on Thursday, November 14th. Morgan Stanley decreased their price objective on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a research report on Tuesday, January 21st. Finally, JPMorgan Chase & Co. reiterated a "neutral" rating and set a $20.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of $21.55.

Ardent Health Partners Stock Performance

NYSE:ARDT traded down $0.98 during trading hours on Friday, reaching $13.86. The company had a trading volume of 527,624 shares, compared to its average volume of 337,948. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The business's 50-day simple moving average is $15.39 and its two-hundred day simple moving average is $16.88. Ardent Health Partners, LLC has a twelve month low of $13.63 and a twelve month high of $20.72.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.